| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/26/2023 |
4
| HEATON LARRY C II (CEO) has filed a Form 4 on Zomedica Corp.|
Txns:
| Bought 100,000 shares
@ $0.1909, valued at
$19.1k
|
|
| 05/25/2023 |
4
| POWERS JOHNNY D (Director) has filed a Form 4 on Zomedica Corp.|
Txns:
| Bought 100,000 shares
@ $0.1934, valued at
$19.3k
|
|
| 05/11/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 05/09/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/20/2023 |
4
| Donato Peter (CFO) has filed a Form 4 on Zomedica Corp.|
Txns:
| Granted 5,000,000 options to buy
@ $0.24, valued at
$1.2M
|
|
| 03/20/2023 |
3
| Donato Peter (CFO) has filed a Form 3 on Zomedica Corp. |
| 03/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Separation Agreement, between Zomedica Inc. and Ann Marie Cotter",
"Offer Letter, between Zomedica Inc. and Peter Donato",
"Zomedica Appoints New Chief Financial Officer ANN ARBOR, MI / ACCESSWIRE / March 17, 2023 / Zomedica Corp . , a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its Chief Financial Officer, effective March 16, 2023. Mr. Donato brings over 30 years of public and private company experience in a wide range of finance and business functions primarily in the human health sector, having held a number of senior positions from CFO, President and CEO, Executive Vice President, Senior Vice President, Vice President and Controller. Prior to joining Zomedica, Mr. Donato had a successful consulting practice specializing in public company readiness and was the Chief Financial Officer of Standar..." |
|
| 03/15/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/15/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Rowe Jeffrey M (Director) has filed a Form 4 on Zomedica Corp.|
Txns:
| Granted 1,465,727 options to buy
@ $0.19, valued at
$278.5k
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/06/2022 |
4
| HEATON LARRY C II (CEO) has filed a Form 4 on Zomedica Corp.|
Txns:
| Granted 4,000,000 options to buy
@ $0.22, valued at
$880k
|
|
| 09/02/2022 |
4
| Nichols Pamela (Director) has filed a Form 4 on Zomedica Corp.|
Txns:
| Granted 800,000 options to buy
@ $0.25, valued at
$200k
|
|
| 09/02/2022 |
3
| Nichols Pamela (Director) has filed a Form 3 on Zomedica Corp. |
| 08/24/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/15/2022 |
8-K
| Quarterly results |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/20/2022 |
8-K
| Quarterly results |
| 07/08/2022 |
8-K
| Quarterly results |
|